Logo image of ACNT

ASCENT INDUSTRIES CO (ACNT) Stock Fundamental Analysis

NASDAQ:ACNT - Nasdaq - US8715651076 - Common Stock - Currency: USD

13.03  +0.07 (+0.54%)

After market: 13.11 +0.08 (+0.61%)

Fundamental Rating

4

Taking everything into account, ACNT scores 4 out of 10 in our fundamental rating. ACNT was compared to 157 industry peers in the Metals & Mining industry. ACNT has a great financial health rating, but its profitability evaluates not so good. ACNT has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

ACNT had negative earnings in the past year.
In the past year ACNT had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: ACNT reported negative net income in multiple years.
Each year in the past 5 years ACNT had a positive operating cash flow.
ACNT Yearly Net Income VS EBIT VS OCF VS FCFACNT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M 30M

1.2 Ratios

ACNT has a Return On Assets of -6.82%. This is in the lower half of the industry: ACNT underperforms 65.61% of its industry peers.
ACNT has a Return On Equity of -11.41%. This is in the lower half of the industry: ACNT underperforms 62.42% of its industry peers.
Industry RankSector Rank
ROA -6.82%
ROE -11.41%
ROIC N/A
ROA(3y)-5.78%
ROA(5y)-4.58%
ROE(3y)-7.62%
ROE(5y)-7.75%
ROIC(3y)N/A
ROIC(5y)N/A
ACNT Yearly ROA, ROE, ROICACNT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30

1.3 Margins

Looking at the Gross Margin, with a value of 15.37%, ACNT is in line with its industry, outperforming 49.04% of the companies in the same industry.
ACNT's Gross Margin has improved in the last couple of years.
ACNT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 15.37%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.87%
GM growth 5Y4.26%
ACNT Yearly Profit, Operating, Gross MarginsACNT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10

More info and screens

8

2. Health

2.1 Basic Checks

ACNT does not have a ROIC to compare to the WACC, probably because it is not profitable.
ACNT has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, ACNT has more shares outstanding
ACNT has a better debt/assets ratio than last year.
ACNT Yearly Shares OutstandingACNT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
ACNT Yearly Total Debt VS Total AssetsACNT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

An Altman-Z score of 3.10 indicates that ACNT is not in any danger for bankruptcy at the moment.
ACNT has a Altman-Z score (3.10) which is in line with its industry peers.
ACNT has a debt to FCF ratio of 0.12. This is a very positive value and a sign of high solvency as it would only need 0.12 years to pay back of all of its debts.
ACNT has a better Debt to FCF ratio (0.12) than 94.27% of its industry peers.
A Debt/Equity ratio of 0.01 indicates that ACNT is not too dependend on debt financing.
ACNT has a better Debt to Equity ratio (0.01) than 73.89% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.12
Altman-Z 3.1
ROIC/WACCN/A
WACC9.58%
ACNT Yearly LT Debt VS Equity VS FCFACNT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

ACNT has a Current Ratio of 2.95. This indicates that ACNT is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of ACNT (2.95) is better than 61.78% of its industry peers.
ACNT has a Quick Ratio of 2.60. This indicates that ACNT is financially healthy and has no problem in meeting its short term obligations.
ACNT's Quick ratio of 2.60 is fine compared to the rest of the industry. ACNT outperforms 69.43% of its industry peers.
Industry RankSector Rank
Current Ratio 2.95
Quick Ratio 2.6
ACNT Yearly Current Assets VS Current LiabilitesACNT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 96.22% over the past year.
ACNT shows a decrease in Revenue. In the last year, the revenue decreased by -6.70%.
Measured over the past years, ACNT shows a very negative growth in Revenue. The Revenue has been decreasing by -10.24% on average per year.
EPS 1Y (TTM)96.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%85.19%
Revenue 1Y (TTM)-6.7%
Revenue growth 3Y-19%
Revenue growth 5Y-10.24%
Sales Q2Q%-43.94%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y229.52%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year6.79%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ACNT Yearly Revenue VS EstimatesACNT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M
ACNT Yearly EPS VS EstimatesACNT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2023 2024 2025 0 1 -1 -2 -3 -4

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

ACNT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 15.97, which indicates a correct valuation of ACNT.
Based on the Price/Forward Earnings ratio, ACNT is valued a bit cheaper than the industry average as 62.42% of the companies are valued more expensively.
ACNT's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 35.28.
Industry RankSector Rank
PE N/A
Fwd PE 15.97
ACNT Price Earnings VS Forward Price EarningsACNT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60

4.2 Price Multiples

ACNT's Enterprise Value to EBITDA is on the same level as the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ACNT indicates a rather cheap valuation: ACNT is cheaper than 91.08% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 10.48
EV/EBITDA 15.89
ACNT Per share dataACNT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

ACNT's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ACNT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ASCENT INDUSTRIES CO

NASDAQ:ACNT (8/8/2025, 4:02:15 PM)

After market: 13.11 +0.08 (+0.61%)

13.03

+0.07 (+0.54%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)08-04 2025-08-04/amc
Earnings (Next)11-10 2025-11-10/amc
Inst Owners49.51%
Inst Owner ChangeN/A
Ins Owners18.68%
Ins Owner Change4.56%
Market Cap123.78M
Analysts85.71
Price TargetN/A
Short Float %4.29%
Short Ratio2.65
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-116.34%
Min EPS beat(2)-165.36%
Max EPS beat(2)-67.32%
EPS beat(4)1
Avg EPS beat(4)-88.41%
Min EPS beat(4)-212.04%
Max EPS beat(4)91.09%
EPS beat(8)1
Avg EPS beat(8)-352.99%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-32.24%
Min Revenue beat(2)-50.42%
Max Revenue beat(2)-14.07%
Revenue beat(4)0
Avg Revenue beat(4)-24.51%
Min Revenue beat(4)-50.42%
Max Revenue beat(4)-8.54%
Revenue beat(8)1
Avg Revenue beat(8)-20.06%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 15.97
P/S 0.78
P/FCF 10.48
P/OCF 9.02
P/B 1.36
P/tB 1.47
EV/EBITDA 15.89
EPS(TTM)-0.17
EYN/A
EPS(NY)0.82
Fwd EY6.26%
FCF(TTM)1.24
FCFY9.54%
OCF(TTM)1.44
OCFY11.08%
SpS16.68
BVpS9.6
TBVpS8.89
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.82%
ROE -11.41%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 15.37%
FCFM 7.45%
ROA(3y)-5.78%
ROA(5y)-4.58%
ROE(3y)-7.62%
ROE(5y)-7.75%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.87%
GM growth 5Y4.26%
F-Score6
Asset Turnover1.04
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.12
Debt/EBITDA 0.14
Cap/Depr 27.41%
Cap/Sales 1.2%
Interest Coverage N/A
Cash Conversion 197.78%
Profit Quality N/A
Current Ratio 2.95
Quick Ratio 2.6
Altman-Z 3.1
F-Score6
WACC9.58%
ROIC/WACCN/A
Cap/Depr(3y)34.33%
Cap/Depr(5y)30.57%
Cap/Sales(3y)1.26%
Cap/Sales(5y)1.14%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)96.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%85.19%
EPS Next Y229.52%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-6.7%
Revenue growth 3Y-19%
Revenue growth 5Y-10.24%
Sales Q2Q%-43.94%
Revenue Next Year6.79%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y99.9%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year361.19%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-14.49%
FCF growth 3Y-10.03%
FCF growth 5Y-11.9%
OCF growth 1Y-26.17%
OCF growth 3Y-8.33%
OCF growth 5Y-12.51%